Showing results (481-490 of 701) with videos related to
Sort By:
Pageof 71
Nutrition and Cancer|August 23, 2016
Colonic Saturated Fatty Acid Concentrations and Expression of COX-1, but not Diet, Predict Prostaglandin E2 in Normal Human Colon TissueElKhansa Sidahmed, Ananda Sen, Jianwei Ren, et al.Cancer|April 1, 1977
Plasma prostaglandins in hypercalcemic patients with neoplastic diseaseL M Demers, J C Allegra, H A Harvey, et al.Journal of Materials Science. Materials in Medicine|June 27, 2013
Ultrathin sP(EO-stat-PO) hydrogel coatings are biocompatible and preserve functionality of surface bound growth factors in vivoCarl Neuerburg, Stefan Recknagel, Jörg Fiedler, et al.American Journal of Medical Genetics|January 15, 1993
Immunohistochemical localization of interstitial collagens in bone tissue from patients with various forms of osteogenesis imperfectaA G Nerlich, R E Brenner, I Wiest, et al.Plos One|October 21, 2014
Guidance of mesenchymal stem cells on fibronectin structured hydrogel filmsAnnika Kasten, Tamara Naser, Kristina Brüllhoff, et al.Cells|March 29, 2023
Terminal Complement Activation Is Induced by Factors Released from Endplate Tissue of Disc Degeneration Patients and Stimulates Expression of Catabolic Enzymes in Annulus Fibrosus CellsAmelie Kuhn, Jana Riegger, Graciosa Q Teixeira, et al.Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Medicas E Biologicas|April 27, 2001
Metabolite and light regulation of metabolism in plants: lessons from the study of a single biochemical pathwayI C Oliveira, E Brenner, J Chiu, et al.Proceedings of the National Academy of Sciences of the United States of America|May 1, 1988
Doxorubicin cardiotoxicity may be caused by its metabolite, doxorubicinolR D Olson, P S Mushlin, D E Brenner, et al.Diabetes, Obesity & Metabolism|February 22, 2011
Saxagliptin, a potent, selective inhibitor of DPP-4, does not alter the pharmacokinetics of three oral antidiabetic drugs (metformin, glyburide or pioglitazone) in healthy subjectsC G Patel, D Kornhauser, N Vachharajani, et al.Journal of Medicinal Chemistry|December 14, 2004
Synthetic bryostatin analogues activate the RasGRP1 signaling pathwayJames C Stone, Stacey L Stang, Yong Zheng, et al.Pageof 71